Efficacy and safety of long-acting beta-2-agonists
نویسندگان
چکیده
منابع مشابه
Efficacy and safety of conventional long acting β2- agonists: systematic review and meta-analysis
Background: Chronic obstructive pulmonary disease (COPD) is usually considered one of the leading causes of death worldwide, so finding proper therapeutic strategies for this disease is of high importance. In this meta-analysis, we reviewed the existing literature on the efficacy and safety of conventional long acting beta agonists (LABAs) in COPD patients. Methods: We searched MEDLINE and G...
متن کاملSafety of long-acting beta-agonists.
Beta2-adrenoceptor agonists have been used as bronchodilators in the management of bronchial asthma and chronic obstructive pulmonary disease (COPD); however, there is evidence suggesting that beta2adrenoceptor agonist use may increase morbidity and mortality1. The long term beta-agonists, salmeterol and formeterol were introduced at the time of heightened concern about safety of beta2 agonist ...
متن کاملSafety of long-acting beta agonists in adults with asthma.
Practice Pointers Asthma affects 8.2% of the U.S. population, and disproportionately affects those who are poor and black. Despite effective therapies, 3,404 U.S. deaths were attributed to asthma in 2010.1 Two types of inhaled pharmacologic agents are used for asthma control: inhaled corticosteroids and LABAs. Concerns about the safety of LABAs have risen with reports of increased hospital admi...
متن کاملSafety of Long-Acting Beta-Agonists in Children with Asthma.
n engl j med 375;9 nejm.org September 1, 2016 889 globulin mucin 3 (TIM-3) or other checkpoints,4 and recently identified mechanisms of primary resistance to PD-1–PD-L1 blockade, which include transcriptional signatures in the tumor microenvironment (innate anti–PD-1 resistance signature, or IPRES5) and the presence of somatic differences in tumor cells (constitutive activation of β-catenin6 or...
متن کاملSafety of Long - Acting Beta - Agonists in Asthma ASTHMA THERAPY
THE EUROPEAN JOURNAL OF RESPIRATORY MEDICINE VOL I ISSUE I Although there was no attempt to determine degree of adherence with ICS at randomisation or persistence in their use during the course of the study, no significant differences were seen for primary events and asthma-related events, including deaths in the total population of patients receiving ICS at baseline. However, in the total popu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Russian Pulmonology
سال: 2015
ISSN: 0869-0189
DOI: 10.18093/0869-0189-2015-25-1-113-118